Impact of 7-ketocholesterol and very long chain fatty acids on oligodendrocyte lipid membrane organization: Evaluation via LAURDAN and FAMIS spectral image analysis

Cytometry Part A

Volumn 79 A, Issue 4, 2011, Pages 293-305

  Kahn, Edmond ^a,e   Baarine, Mauhamad ^b   Dauphin, Aurélien ^c   Ragot, Kévin ^b   Tissot, Nicolas ^c   Seguin, Alix ^b   Ménétrier, Franck ^d   Kattan, Zilal ^b   Bachelet, Claude Marie ^c   Frouin, Frédérique ^a   Lizard, Gérard ^b,e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^e Chu   (France)

Author keywords

158N oligodendrocytes; 7 ketocholesterol; FAMIS; LAURDAN; Mono and bi photon confocal microscopy; Very long chain fatty acids

Indexed keywords

2 NAPHTHYLAMINE; 7 OXOCHOLESTEROL; 7-KETOCHOLESTEROL; ALPHA CYCLODEXTRIN; ALPHA CYCLODEXTRIN DERIVATIVE; ALPHA-CYCLODEXTRIN; CHOLESTEROL DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; FATTY ACID; FLUORESCENT DYE; LAURDAN; LAURIC ACID DERIVATIVE; MEMBRANE LIPID;

ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; MALE; METHODOLOGY; MOUSE; OLIGODENDROGLIA; ULTRASTRUCTURE; ANALOGS AND DERIVATIVES; DRUG EFFECTS; PROCEDURES;

2-NAPHTHYLAMINE; ALPHA-CYCLODEXTRINS; ANIMALS; CELL MEMBRANE; ENZYME INHIBITORS; FATTY ACIDS; FLUORESCENT DYES; KETOCHOLESTEROLS; LAURATES; MALE; MEMBRANE LIPIDS; MICE; MICROSCOPY, CONFOCAL; OLIGODENDROGLIA;

EID: 79953016042     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.21017     Document Type: Article

References (55)

1. Börkhem I, Meaney S. Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806-815.
2. Harauz G, Ishiyama N, Hill C, Bates IR, Libich DS, Farès C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 2004; 35: 503-542.
3. Taylor CM, Marta CB, Claycomb RJ, Han DK, Rasband MN, Coetzee T, Pfeiffer SE. Proteomic mapping provides powerful insights into functional myelin biology. Proc Natl Acad Sci USA 2004; 101: 4643-4648.
4. Hörster F, Surtees R, Hoffmann GF. Disorders of intermediary metabolism: Toxic leukoencephalopathies. J Inherit Metab Dis 2005; 28: 345-356.
5. Chang JY, Liu LZ. Neurotoxicity of cholesterol oxides on cultured cerebellar granule cells. Neurochem Int 1998; 32: 317-323.
6. Schroepfer GJ. Oxysterols: Modulators of cholesterol metabolism and other processesses. Physiol Rev 2000; 80: 361-554.
7. Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 2009; 30: 153-170.
8. Diestel A, Aktas O, Hackel D, Hake I, Meier S, Raine CS, Nitsch R, Zipp F, Ullrich O. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: A link between demyelination and neuronal damage. J Exp Med 2003; 198: 1729-1740.
9. Leoni V, Lütjohann D, Masterman T. Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res 2005; 46: 191-195.
10. Depreter M, Espeel M, Roels F. Human peroxisomal disorders. Microsc Res Tech 2003; 61: 203-223.
11. Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006; 75: 295-332.
12. Baes M, Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009; 15: 367-379.
13. Kassmann C, Lappe-Siefke C, Baes M, Brügger B, Mildner A, Werner HK, Natt O, Michaelis T, Prinz M, Frahm J, Nave KA. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007; 39: 969-976.
14. Wanders RJ, Waterham HR. Peroxysomal disorders: The single peroxisomal enzyme deficiencies. Biochim Biophys Acta 2006; 1763: 1707-1720.
15. Schrader M, Fahimi HD. The peroxisome: Still a mysterious organelle. Histochem Cell Biol 2008; 129: 421-440.
16. Aubourg P, Dubois-Dalcq M. X-linked adrenoleukodystrophy enigma: How does the ALD peroxisomal transporter mutation affect CNS glia? Glia 2000; 29: 186-190.
17. Berger J, Gartner J. X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 2006; 1763: 1721-1732.
18. Kemp S, Wanders RJ. X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism. ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007; 90: 268-276.
19. Takemoto Y, Suzuki Y, Horibe R, Shimozawa N, Wanders RJ, Kondo N. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 2003; 25: 481-487.
20. Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, Frosch MP, Ransohoff RM. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 2008; 63: 729-742.
21. Bagatolli LA. Direct observation of lipid domains in free standing bilayers: From simple to complex lipid mixtures. Chem Phys Lipids 2003; 122: 137-145.
22. Bagatolli LA. To see or not to see: Lateral organization of biological membranes and fluorescence microscopy. Biochim Biophys Acta 2006; 1758: 1541-1556.
23. Feutz AC, Pham-Dinh D, Allinquant B, Miehe M, Ghandour S. An immortalized jimpy oligodendrocyte cell line: Defects in cell cycle and cAMP pathway. Glia 2001; 34: 241-252.
24. Ghandour S, Feutz AM, Jalabi W, Taleb O, Bessert D, Cypher M, Carlock L, Skoff RP. Trafficking of PLP/DM20 and cAMP signalling in immortalized jimpy oligodendrocytes. GLIA 2002; 40: 300-311.
25. Baarine M, Ragot K, Genin EC, El Hajj H, Trompier D, Andreoletti P, Ghandour MS, Menetrier F, Cherkaoui-Malki M, Savary S, Lizard G. Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): Potential models for the study of peroxisomal disorders associated with dysmyelination processes. J Neurochem 2009; 111: 119-131.
26. Lizard G, Deckert V, Dubrez L, Moisant M, Gambert P, Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol 1996; 148: 1625-1638.
27. Singh I, Kishimoto Y. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. J Lipid Res 1983; 24: 662-625.
28. Yeh CJ, Hsi BL, Faulk, WP. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J Immunol Methods 1981; 1981; 43: 269-275.
29. Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard JP. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995; 21: 275-283.
30. Wlodkowic D, Skommer J, Darzynkiewicz Z. SYTO probes in the cytometry of tumor cell death. Cytometry A 2008; 73: 496-507.
31. Wlodkowic D, Skommer J, Pelkonen J. Towards an understanding of apoptosis detection by SYTO dyes. Cytometry A 2007; 71: 61-72.
32. Schlegel RA, Stevens M, Lumley-Sapanski K, Williamson P. Altered lipid packing identifies apoptotic cells. Immunol Lett 1993; 36: 283-288.
33. Laakko T, King L, Fraker P. Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells. J Immunol Methods 2002; 61: 129-139.
34. Di Paola R, Bazin JP, Aubry F, Aurengo A, Cavaillolès F, Herry JH, Kahn E. Handling of dynamic sequences in nuclear medecine. IEEE Trans Nucl Sci 1982; 29: 1310-1321.
35. Frouin F, Cinotti L, Benali H, Buvat I, Bazin JP, Millet P, Di Paola R. Extraction of functional volumes from medical dynamic volumetric datasets. Comp Med Imaging Graph 1993; 17: 397-404.
36. Kahn E, Lizard G, Pélégrini M, Frouin F, Roignot P, Chardonnet Y, Di Paola R. Four-dimensional factor analysis of confocal images sequences (4D-FAMIS) to detect and characterize low numbers of human papillomavirus DNA by FISH in HeLa and SiHa cells. J Microscopy 1999; 193: 227-243.
37. Kahn E, Frouin F, Souchier C, Bernengo JC, Bruzzoni-Giovanelli H, Clement O, Frija G, Di Paola R, Calvo F, Linares-Cruz G. Confocal multilaser focusing and single-laser characterization of UV excitable stains of cellular preparations. Cytometry 2000; 40: 42-49.
38. Harman HH. Modern Factor Analysis. Chicago: University of Chicago Press; 1960.
39. Benzecri JP. L'analyse des données, Tome 2: L'analyse des correspondances. Paris: Dunod; 1973.
40. Vejux A, Guyot S, Montange T, Riedinger JM, Kahn E, Lizard G. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J Nutr Biochem 2009; 20: 45-61.
41. Kahn E, Lizard G, Frouin F, Bernengo JC, Souchier C, Bessède G, Clément O, Siitari H, Gambert P, Frija G, Todd-Pokropek A. Confocal analysis of phosphatidylserine externalization with the use of biotinylated annexin V revealed with streptavidin-FITC, -europium, -phycoerythrin or -Texas Red in oxysterol-treated apoptotic cells. Anal Quant Cytol Histol 2001; 23: 47-55.
42. Vejux A, Malvitte L, Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 2008; 41: 545-556.
43. Kahn E, Hotmar J, Frouin F, Di Paola M, Bazin JP, Di Paola R, Bernheim A. Spectral and dynamic confocal fluorescence characterization of cytogenetic preparations. Anal Cell Pathol 1996; 12: 45-56.
44. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-468.
45. Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 2003; 79: 189-196.
46. Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, Smith KD, Powers JM. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: Morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 2001; 60: 1004-1019.
47. Feigenbaum V, Gélot A, Casanova P, Daumas-Duport C, Aubourg P, Dubois-Dalcq M. Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients. Neurobiol Dis 2000; 7 (6 Part B): 600-612.
48. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81: 871-927.
49. Yuan XM, Li W, Brunk UT, Dalen H, Chang YH, Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 2000; 28: 208-218.
50. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, Bessède G, Corcos L, Gambert P, Néel D, Lizard G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005; 21: 97-114.
51. Lassmann H. Cellular damage and repair in multiple sclerosis. In: Lazzarini RA, editor. Myelin Biology and Disorders, Vol 2. USA: Elsevier; 2004. pp 733-762.
52. Darzynkiewicz Z, Bedner E, Smolewski P, Lee BW, Johnson GL. Detection of caspases activation in situ by fluorochrome-labeled inhibitors of caspases (FLICA). Methods Mol Biol 2002; 203: 289-299.
53. Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 2003; 14: 425-439.
54. Singh I, Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis. Brain Pathol 2010; 20: 838-844.
55. Wanders RJ, Ferdinandusse S, Brites P, Kemp S. Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 2010; 1801: 272-280.